Leidos (LDOS) Projected to Post Earnings on Tuesday

Leidos (NYSE:LDOS) will likely be issuing its Q4 2025 results before the market opens on Tuesday, February 17th. Analysts expect Leidos to post earnings of $2.54 per share and revenue of $4.3143 billion for the quarter. Parties can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, February 17, 2026 at 8:00 AM ET.

Leidos Price Performance

Shares of NYSE:LDOS opened at $175.90 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.50 and a debt-to-equity ratio of 0.94. The stock has a market cap of $22.49 billion, a PE ratio of 16.41, a price-to-earnings-growth ratio of 1.23 and a beta of 0.59. The stock’s fifty day simple moving average is $188.17 and its two-hundred day simple moving average is $186.36. Leidos has a 1-year low of $123.62 and a 1-year high of $205.77.

Insider Transactions at Leidos

In other Leidos news, insider Elizabeth A. Porter sold 3,000 shares of the company’s stock in a transaction dated Tuesday, January 20th. The shares were sold at an average price of $192.21, for a total transaction of $576,630.00. Following the sale, the insider directly owned 38,575 shares of the company’s stock, valued at $7,414,500.75. This represents a 7.22% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.96% of the company’s stock.

Hedge Funds Weigh In On Leidos

Several hedge funds have recently bought and sold shares of LDOS. Wexford Capital LP purchased a new stake in Leidos in the 3rd quarter worth approximately $32,000. Kelleher Financial Advisors purchased a new stake in shares of Leidos in the third quarter worth $46,000. Wilkerson Advisory Group LLC bought a new stake in Leidos during the fourth quarter valued at $45,000. Towarzystwo Funduszy Inwestycyjnych PZU SA grew its position in Leidos by 58.8% during the third quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 270 shares of the aerospace company’s stock worth $51,000 after buying an additional 100 shares in the last quarter. Finally, Jessup Wealth Management Inc bought a new position in Leidos in the 4th quarter worth about $53,000. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on LDOS shares. Weiss Ratings reissued a “buy (b)” rating on shares of Leidos in a research report on Monday, December 29th. Citigroup lifted their target price on shares of Leidos from $218.00 to $232.00 and gave the stock a “buy” rating in a research report on Tuesday, January 13th. UBS Group set a $204.00 target price on Leidos in a report on Thursday, January 15th. Truist Financial reiterated a “buy” rating and set a $220.00 price target (up from $200.00) on shares of Leidos in a report on Tuesday, November 4th. Finally, Wall Street Zen upgraded Leidos from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 31st. Nine analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $213.09.

About Leidos

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.